Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection

2026-03-01 14:30:00 ET

Jean M. Franchi, Chief Financial Officer of Disc Medicine (NASDAQ:IRON) , executed open-market sales of 11,156 shares for approximately $720,000 across three transactions on Feb. 17 and Feb. 18, 2026, as disclosed in a recent SEC Form 4 filing .

Transaction value based on SEC Form 4 weighted average purchase price ($64.51); post-transaction value based on Feb. 18, 2026 weighted average price ($64.51).

Continue reading